Marksans Pharma Ltd. NSE: MARKSANS | BSE: 524404

Mid-range Performer

Download real time

171.40 0.08 (0.05%)

Near 52W Low of ₹165.52

146.4K

NSE+BSE Volume

NSE 24 Sep, 2025 9:42 AM (IST)

Drug Approval

Marksans Pharma's UK arm gets MHRA approval for moxonidine tablets with a market size of $1.2 bn See details

Marksans Pharma Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Marksans Pharma Ltd. from all sources in a single place.

Load latest

Is Marksans Pharma Ltd. worth buying?

1421 Votes:

Buy 80.44%

Sell 10.2%

Hold 9.36%